AltPlus Holdings Inc.
Notice of Extraordinary Loss (Impairment Loss on Affiliated Company Shares and Impairment Loss) and Non-operating Expense (Equity-method Investment Loss) and Related Impacts
For the fourth quarter of the fiscal year ending September 2026, an impairment loss on shares of an affiliated company and an equity-method investment loss were recorded as an extraordinary loss and non-operating expense. These affect the consolidated financial statements but are recorded in the separate financial statements as well; impairments have occurred and have been reflected in the published financial summary.
Key Figures
- Impairment loss on shares of affiliated company: 557,249 thousand yen
- Equity-method investment loss: 533,246 thousand yen
- Impairment loss on fixed assets: 10,270 thousand yen
AI要約
Recording of Extraordinary Losses and Non-operating Expenses
In the fourth quarter of the fiscal year ending September 2026, an impairment loss on shares of an affiliated company of 557,249 thousand yen was recorded in the separate financial statements. In the consolidated financial statements, related to this impairment, an equity-method investment loss of 533,246 thousand yen, including a one-time write-off of goodwill-equivalent amounts, was recorded as a non-operating expense. These items are reflected in the financial summary.
Impairment Treatment and Impact on Performance
The company also performed impairment on business assets and recorded an impairment loss of 10,270 thousand yen as an extraordinary loss. These losses affect both consolidated and separate financial reporting, and the impact on the consolidated statements is as described in the disclosure document.
AltPlus Holdings Inc.
Company overview · Stock price · Financial data · All IR
